The Philadelphia Court of Common Pleas has ruled in favor of Bayer in a Roundup lawsuit. In a press release, Bayer officials ...

In 2022, despite harsh covid-19 lockdowns, 25 new foreign R&D centres opened in Shanghai. Last year, when overall foreign ...

Patients with advanced SSC of the anal canal have a marked survival benefit when immunotherapy is added to standard-of-care ...

After a surprise failure in advanced liver cancer, Merck & Co. and Eisai are hoping new data can make their Keytruda-Lenvima combination a standard of care in intermediate-stage disease. | After a ...

Cellino Biotech, which was founded in 2017, won a federal grant worth up to $25 million to continue to develop its advanced ...

Bayer BAYRY announced positive results from the expansion part of the ongoing early to mid-stage study on pipeline candidate ...

Matt Gline is back with a new ‘vant’ company, after the Roivant Sciences CEO paid Bayer $14 million upfront for the rights to ...

Some patients with non-small cell lung cancer (NSCLC) have mutations in a gene called human epidermal growth factor receptor 2 (HER2), which drives their disease progression. | Some patients with ...

Within the new Golden Ticket program of Bayer, Genvor to receive fully funded access to lab space and equipment in California ...

Bayer BAYRY announced encouraging detailed results from the late-stage FINEARTS-HF study on finerenone. Finerenone is marketed as Kerendia or Firialta in some countries. The drug is approved for ...